Verrica stockholders elect three directors, approve reverse split authorization at annual meeting

Verrica Pharmaceuticals Inc.

Elected directors Sean Stalfort (60.3M for), Diem Nguyen (58.8M for), Gavin Corcoran (63.0M for).
Advisory vote on named executive officer compensation approved: 62.4M for, 1.3M against.
Ratification of KPMG LLP as auditor for FY2025 approved: 81.9M for, 1.5M against.
Approved reverse stock split authorization at ratio of 1-for-10 to 1-for-30, board discretion.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.